Nonetheless, targeting NCAPG in HCC tumor cells will likely achieve the compound effect of fewer and slower cell divisions, a fragmented mitochondrial network, and cell death, resulting in significantly impaired tumor cell growth in vitro and in vivo. The gene discussed is NCAPG; the disease is neoplasm.